Calvin L. Blue

Calvin L. Blue serves as a Contract Specialist responsible for managing the acquisition lifecycle for complex medical and scientific procurement needs. In this role, he ensures compliance with federal acquisition regulations while facilitating timely and cost-effective contract awards that support mission-critical operations. His portfolio primarily encompasses the procurement of diagnostic reagents, surgical supplies, laboratory instrumentation, and pharmaceutical preparations, requiring deep technical understanding of regulatory standards and supply chain dynamics. He works closely with program managers, technical evaluators, and legal advisors to structure solicitations that balance performance requirements with socioeconomic objectives. While specific contractor names are not available, Calvin consistently engages with a diverse pool of vendors, including both large-scale manufacturers and small businesses specializing in life sciences and healthcare technology. His procurement approach emphasizes competitive bidding, clear performance metrics, and rigorous source selection procedures, fostering transparent and accountable vendor relationships. He prioritizes vendors with proven quality control systems and regulatory certifications, particularly those aligned with FDA and ISO standards. Calvin demonstrates a strong commitment to small business participation, with nearly 17.2% of his awards designated as total small business set-asides under FAR 19.5. While the majority of his acquisitions remain open to all competitors, his consistent use of small business set-asides reflects a deliberate strategy to expand market access for qualified small manufacturers. His patterns indicate a preference for general small business eligibility over niche socioeconomic categories such as 8(a) or HUBZone, suggesting a focus on broad-based economic opportunity within the manufacturing sector. His primary NAICS focus centers on in-vitro diagnostic substance manufacturing, surgical appliance production, and analytical laboratory instrument manufacturing, underscoring his expertise in life sciences procurement. He also regularly acquires educational support services and pharmaceutical preparations, indicating a multidisciplinary portfolio that spans research, clinical, and training environments. Calvin’s technical acumen enables him to navigate complex specifications for medical devices and reagents, ensuring procurement actions align with evolving public health and scientific standards.